Our blogs explain health conditions and clinical research in a way that is easy to follow, so readers can feel more informed
Chimerix Gets FDA OK to Test Drug for Ebola
A North Carolina drugmaker plans to test its experimental antiviral drug in patients who have Ebola, after getting authorization from regulators at the Food and Drug Administration. Chimerix Inc. said that it has received FDA clearance to proceed with a trial...
Ebola Death Rate Rises to 70%
West Africa could face up to 10,000 new Ebola cases a week within two months, the World Health Organization warned Tuesday, adding that the Ebola mortality rate in the current outbreak has risen to 70 percent. WHO assistant director-general Dr. Bruce...
CDC Urges All U.S. Hospitals to Think ‘Ebola’
At FOMAT, infectious disease preparedness is something we take seriously as a clinical research organization that operates within healthcare settings. The Ebola outbreak of 2014 was a pivotal moment that reshaped how hospitals and research sites think about infection control protocols,...
EBC 46 Human Trials Destroy Tumors
Scientists at QIMR Berghofer Medical Research Institute have used an experimental drug produced from the seeds of a rainforest plant to cure solid cancer tumors in preclinical trials. The study led by Dr. Glen Boyle at QIMR Berghofer’s Cancer Drug Mechanisms...
1st Ebola Patient Diagnosed in the US Has Died
The first Ebola patient diagnosed in the United States died Wednesday morning in a Dallas hospital, according to a hospital spokesman. Thomas Eric Duncan was pronounced dead at 7:51 a.m. at Texas Health Presbyterian Hospital Dallas, where he was admitted Sept....
Experimental Drug Provided to Dallas Ebola Patient
A North Carolina drugmaker is providing its experimental antiviral drug to a Dallas patient being treated for Ebola, an emergency step authorized by the Food and Drug Administration. Officials at Texas Health Presbyterian Hospital said Monday that their patient, Thomas Eric...
Vivolux Cancer Drug Receives FDA Clearance for Clinical Study
Vivolux, a pharmaceutical company specialized in cancer treatment, announced that the FDA has granted clearance to proceed with VLX1570 Clinical Trial phase 1/2 for treatment against relapsed and/or refractory multiple myeloma. Researchers at Vivolux have discovered a novel cancer drug target...
Liberia to Prosecute Man Who Brought Ebola to U.S.
Liberia plans to prosecute the airline passenger who brought Ebola into the U.S., alleging that he lied on an airport questionnaire about not having any contact tracing with an infected person, authorities said Thursday. Thomas Eric Duncan filled out a series...
Ebola Treatment Makers Rise After First U.S. Case
Shares of several drugmakers involved in Ebola vaccine development rose in premarket trading, continuing a run that started after federal officials confirmed the first case of the disease in the United States. Tekmira Pharmaceuticals Corp., Inovio Pharmaceuticals Inc. and NewLink Genetics...
10 Questions, Answers About the U.S. Ebola Case
U.S. health officials have warned for months that someone infected with Ebola could unknowingly carry the virus to this country, and there is word now that it has happened: A traveler in a Dallas hospital became the first patient diagnosed in...
1000s of Ebola Vaccine Doses in Coming Months
Thousands of doses of experimental Ebola vaccines should be available in the coming months and could eventually be given to health care workers and other people at high risk of the deadly disease, according to the World Health Organization. No vaccine...
Simple Blood Test a Possible Tool for Early Cancer Diagnosis
High levels of calcium in blood, a condition known as hypercalcemia, can be used by GPs as an early indication of certain types of cancer, according to a study by researchers from the universities of Bristol and Exeter. Hypercalcemia is the...